Bo Abrahamsen

20.4k total citations · 4 hit papers
295 papers, 11.4k citations indexed

About

Bo Abrahamsen is a scholar working on Orthopedics and Sports Medicine, Oncology and Surgery. According to data from OpenAlex, Bo Abrahamsen has authored 295 papers receiving a total of 11.4k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Orthopedics and Sports Medicine, 99 papers in Oncology and 98 papers in Surgery. Recurrent topics in Bo Abrahamsen's work include Bone health and osteoporosis research (177 papers), Bone health and treatments (97 papers) and Hip and Femur Fractures (83 papers). Bo Abrahamsen is often cited by papers focused on Bone health and osteoporosis research (177 papers), Bone health and treatments (97 papers) and Hip and Femur Fractures (83 papers). Bo Abrahamsen collaborates with scholars based in Denmark, United Kingdom and Australia. Bo Abrahamsen's co-authors include Pia Eiken, Kim Brixen, Cyrus Cooper, Richard Eastell, Peter Vestergaard, Katrine Hass Rubin, Tjeerd van Staa, Rinat Ariely, Melvin Olson and Serge Ferrari and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Bo Abrahamsen

287 papers receiving 11.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Excess mortality following hip fracture: a systematic epidemiological review

2009 828 citations Bo Abrahamsen, Cyrus Cooper et al. Osteoporosis International profile →
Mechanisms of diabetes mellitus-induced bone fragility

2016 777 citations Bo Abrahamsen et al. profile →
Excess mortality in men compared with women following a hip fracture. National analysis of comedications, comorbidity and survival

2010 423 citations Pia Eiken, Bo Abrahamsen et al. Age and Ageing profile →
Fracture Risk and Management of Discontinuation of Denosumab Therapy: A Systematic Review and Position Statement by ECTS

2020 219 citations Bo Abrahamsen, Eugène McCloskey et al. The Journal of Clinical Endocrinology & Metabolism profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Bo Abrahamsen	6.0k	3.5k	3.1k	2.2k	1.3k	295	11.4k
Piet Geusens	6.4k 1.1×	3.4k 1.0×	2.8k 0.9×	2.6k 1.2×	1.4k 1.1×	305	12.8k
Mattias Lorentzon	5.3k 0.9×	2.5k 0.7×	2.1k 0.7×	2.8k 1.3×	1.1k 0.8×	259	10.3k
Adolfo Díez‐Pérez	6.1k 1.0×	3.0k 0.9×	3.4k 1.1×	2.9k 1.3×	1.0k 0.8×	290	10.5k
Susan L. Greenspan	7.1k 1.2×	2.6k 0.7×	4.8k 1.5×	2.9k 1.3×	1.3k 1.0×	175	11.7k
Willem F. Lems	3.6k 0.6×	2.6k 0.7×	2.2k 0.7×	2.8k 1.3×	1.3k 1.0×	406	15.1k
Stuart L. Silverman	7.2k 1.2×	3.7k 1.1×	4.0k 1.3×	2.5k 1.1×	1.5k 1.1×	202	11.8k
Saeko Fujiwara	5.8k 1.0×	3.5k 1.0×	2.2k 0.7×	1.9k 0.9×	979 0.7×	177	10.0k
Lars Rejnmark	4.5k 0.7×	4.9k 1.4×	2.5k 0.8×	2.0k 0.9×	3.6k 2.6×	322	14.5k
Meryl S. LeBoff	6.7k 1.1×	3.2k 0.9×	3.0k 0.9×	3.3k 1.5×	2.6k 2.0×	187	15.2k
Salvatore Minisola	4.3k 0.7×	1.9k 0.5×	3.2k 1.0×	2.1k 0.9×	2.8k 2.0×	307	10.1k

Countries citing papers authored by Bo Abrahamsen

Since Specialization

Citations

This map shows the geographic impact of Bo Abrahamsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo Abrahamsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo Abrahamsen more than expected).

Fields of papers citing papers by Bo Abrahamsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo Abrahamsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo Abrahamsen. The network helps show where Bo Abrahamsen may publish in the future.

Co-authorship network of co-authors of Bo Abrahamsen

This figure shows the co-authorship network connecting the top 25 collaborators of Bo Abrahamsen. A scholar is included among the top collaborators of Bo Abrahamsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo Abrahamsen. Bo Abrahamsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rietz, M., et al.. (2025). Introducing FREMML: a decision-support approach for automated identification of individuals at high imminent fracture risk. Archives of Osteoporosis. 20(1). 140–140.

Möller, Sören, M. Rietz, Jan Christian Brønd, et al.. (2025). An enhanced Fracture Risk Evaluation Model (FREM) using national health data on morbidity and medications. Journal of Bone and Mineral Research. 41(1). 25–37. 1 indexed citations

Händel, Mina Nicole, Niklas Rye Jørgensen, Jonas Bybjerg‐Grauholm, et al.. (2025). Early life determinants of skeletal maturation, body composition and endocrine health in young adults (EPIPEAK): protocol for a nationwide birth cohort study. BMJ Open. 15(10). e101632–e101632.

Tran, Thach, Dana Bliuc, Bo Abrahamsen, et al.. (2024). Multimorbidity clusters potentially superior to individual diseases for stratifying fracture risk in older people: a nationwide cohort study. Age and Ageing. 53(7). 2 indexed citations

Rubin, Katrine Hass, et al.. (2024). Biological Heterogeneity in Susceptibility to Glucocorticoid-Induced Bone Loss: Short- and Long-Term Hip BMD Trajectories. The Journal of Clinical Endocrinology & Metabolism. 110(8). e2570–e2582. 2 indexed citations

Petersen, Tanja Gram, Bo Abrahamsen, Mette Juel Rothmann, et al.. (2024). Ten-year follow-up of fracture risk in a systematic population-based screening program: the risk-stratified osteoporosis strategy evaluation (ROSE) randomised trial. EClinicalMedicine. 71. 102584–102584. 4 indexed citations

Möller, Sören, Michael Kriegbaum Skjødt, Pernille Just Vinholt, et al.. (2024). Validity of Major Osteoporotic Fracture Diagnoses in the Danish National Patient Registry. Clinical Epidemiology. Volume 16. 257–266. 7 indexed citations

Skjødt, Michael Kriegbaum, et al.. (2023). An enhanced version of FREM (Fracture Risk Evaluation Model) using national administrative health data: analysis protocol for development and validation of a multivariable prediction model. SHILAP Revista de lepidopterología. 7(1). 19–19. 6 indexed citations

Oheim, Ralf, et al.. (2023). Epidemiology of Tumor-Induced Osteomalacia in Germany Based on Real World Data. Calcified Tissue International. 113(6). 630–639. 3 indexed citations

10.

Möller, Sören, Michael Kriegbaum Skjødt, Lin Yan, et al.. (2021). Prediction of imminent fracture risk in Canadian women and men aged 45 years or older: external validation of the Fracture Risk Evaluation Model (FREM). Osteoporosis International. 33(1). 57–66. 16 indexed citations

11.

Händel, Mina Nicole, Ramunë Jacobsen, Amélie Keller, et al.. (2021). Assessing Health Consequences of Vitamin D Fortification Utilizing a Societal Experiment Design: Methodological Lessons Learned from the D-Tect Project. International Journal of Environmental Research and Public Health. 18(15). 8136–8136. 2 indexed citations

12.

Robinson, Danielle E, M. Sanni Ali, Victoria Y. Strauss, et al.. (2021). Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study. Health Technology Assessment. 25(17). 1–106. 3 indexed citations

13.

Skjødt, Michael Kriegbaum, Martin Ernst, Sara Khalid, et al.. (2021). The treatment gap after major osteoporotic fractures in Denmark 2005-2014: a combined analysis including both prescription-based and hospital-administered anti-osteoporosis medications. Osteoporosis International. 32(10). 1961–1971. 15 indexed citations

14.

Ernst, Martin, et al.. (2019). Tramadol prescribed use in general and chronic noncancer pain: a nationwide register-based cohort study of all patients above 16 years. Scandinavian Journal of Pain. 20(1). 109–124. 9 indexed citations

15.

Rubin, Katrine Hass, Marianne Andersen, Bo Abrahamsen, & Dorte Glintborg. (2018). Socioeconomic status in Danish women with polycystic ovary syndrome: A register‐based cohort study. Acta Obstetricia Et Gynecologica Scandinavica. 98(4). 440–450. 18 indexed citations

16.

Khalid, Sana, Martin Ernst, Katrine Hass Rubin, et al.. (2018). SECULAR TRENDS IN THE INITIATION OF THERAPY IN SECONDARY FRACTURE PREVENTION IN EUROPE: A MULTI-NATIONAL STUDY INCLUDING DATA FROM DENMARK, SPAIN, AND THE UK.. Value in Health. 21. 1 indexed citations

17.

Abrahamsen, Bo, et al.. (2016). Predictors of long-term opioid use among chronic nonmalignant pain patients: A register-based national open cohort study. Scandinavian Journal of Pain. 12(1). 120–120. 1 indexed citations

18.

Svedbom, A, E Hernlund, M Ivergård, et al.. (2013). Epidemiology and Economic Burden of Osteoporosis in Denmark. Archives of Osteoporosis. 8. 1 indexed citations

19.

Orwoll, Eric, Bente Langdahl, R. Chapurlat, et al.. (2011). A phase 3 study of the efficacy and safety of Denosumab in men with low bone mineral density : design of the ADAMO. Open Repository and Bibliography (University of Liège). 1 indexed citations

20.

Abrahamsen, Bo, Pia Eiken, & Richard Eastell. (2008). Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study. Journal of Bone and Mineral Research. 24(6). 1095–1102. 269 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact